Endpoints used in Relative Effectiveness Assessment Safety Amended JA1 Guideline Final Nov 2015
WP7-SG3-GL-safety_amend2015
Endpoints used for Relative Effectiveness Assessment Health related quality of life and utility measures Amended JA1 Guideline Final Nov 2015
Endpoints used for Relative Effectiveness Assessment Health related quality of life and utility measures_Amended JA1 Guideline_Final Nov 2015
Endpoints used for Relative Effectiveness Assessment Composite endpoints Amended JA1 Guideline Final Nov 2015
Endpoints used for Relative Effectiveness Assessment Composite endpoints_Amended JA1 Guideline_Final Nov 2015
Endpoints used for Relative Effectiveness Assessment Clinical Endpoints Amended JA1 Guideline Final Nov 2015
WP7-SG3-GL-clin_endpoints_amend2015
EMA and EUnetHTA meet in London on May 8, 2015
Following the agreed schedule of biannual meetings between EUnetHTA and the EMA, the next meeting is held tomorrow (May 8, 2015) in London The final draft agenda for the meeting is available here. The minutes of the meeting will be made publicly available on the EMA-EUnetHTA cooperation page. 2015-05-08 EMA EUnetHTA – Agenda
Draft Agenda EFPIA –EUnetHTA Expert meeting with focus on rapid REAs, October 7, 2015
Draft Agenda of the EFPIA –EUnetHTA Expert meeting with focus on rapid REAs, October 7, 2015, in Diemen, Netherlands. EFPIA-EUnetHTA Expert Meeting_ October7 2015_Agenda
Comparators & Comparisons Criteria for the choice of the most appropriate comparator(s) Amended JA1 Guideline 2015
WP7-SG3-GL-choice_of_comparator_amend2015
Comparators & Comparisons Direct and indirect comparisons Amended JA1 Guideline Final Nov 2015
Comparators & Comparisons Direct and indirect comparisons_Amended JA1 Guideline_Final Nov 2015
6th pilot rapid assessment of WP5 JA2 Strand B on “Endovascular therapy using mechanical thrombectomy devices for acute ischaemic stroke”
The purpose of the assessment is to examine the effectiveness and safety of mechanical thrombectomy in adults aged 18 years or older with acute ischaemic stroke in the anterior and/or posterior region. The analysis included CE-marked aspiration/suction devices, and stent and clot retrievers. Final version of the assessment was published in February 2016 Below is […]
4th pilot rapid assessment of WP5 JA2 Strand B on “Biodegradable stents for the treatment of refractory or recurrent benign oesophageal stenosis”
The purpose of the assessment is to address the research question whether the use of biodegradable stents for benign refractory or recurrent oesophageal stenosis is more effective and/or safer than self-expanding metal or plastic stents or oesophageal dilation. Final version of the assessment was published in May 2015 Below is the documentation provided by the […]
